NCT03547115 2026-03-17A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AMLMEI Pharma, Inc.Phase 1 Terminated84 enrolled
NCT04268277 2026-02-27Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDYUniversity of UlmPhase 2 Terminated22 enrolled 20 charts